Second-trimester induction of labor

Clinical Obstetrics and Gynecology

Volumn 52, Issue 2, 2009, Pages 188-197

  Vargas, Juan ^a   Diedrich, Justin ^a  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

Fetal demise medication abortion; Feticide; Induction of labor; Induction termination; Second trimester abortion

Indexed keywords

ANALGESIC AGENT; DIGOXIN; LIDOCAINE; LOCAL ANESTHETIC AGENT; MIFEPRISTONE; MISOPROSTOL; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXYTOCIN; PLACEBO; POTASSIUM CHLORIDE; PROSTAGLANDIN DERIVATIVE;

ADD ON THERAPY; AMNIOCENTESIS; ARTICLE; CESAREAN SECTION; CHILL; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; CURETTAGE; DIARRHEA; DILATION AND EVACUATION; DIZZINESS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG MEGADOSE; DRUG SAFETY; FEVER; GASTROINTESTINAL SYMPTOM; GESTATIONAL AGE; HUMAN; INCIDENCE; LABOR INDUCTION; LOW DRUG DOSE; MATERNAL DISEASE; MATERNAL MORBIDITY; MATERNAL MORTALITY; MEDICAL ABORTION; MEDICAL STAFF; NAUSEA; OPTIMAL DRUG DOSE; PAIN; PATIENT SAFETY; PLACENTA; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PREGNANCY TERMINATION; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; RESUSCITATION; RETAINED PLACENTA; SECOND TRIMESTER ABORTION; SECOND TRIMESTER PREGNANCY; STOMACH ULCER; SURGICAL ABORTION; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURVIVAL; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT RESPONSE; ULTRASOUND; UNITED STATES; UTERINE CERVIX DILATATION; UTERINE CERVIX RIPENING; UTERUS CONTRACTION; VOMITING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; ADMINISTRATION, INTRAVAGINAL; DILATATION; DRUG THERAPY, COMBINATION; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; MATERNAL MORTALITY; MIFEPRISTONE; MISOPROSTOL; PAIN, POSTOPERATIVE; PREGNANCY; PREGNANCY TRIMESTER, SECOND;

EID: 67650799386     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/GRF.0b013e3181a2b5d5     Document Type: Article

References (27)

1. Jones RK, ZolnaMR, Henshaw SK, et al. Abortion in the United States: incidence and access to services, 2005. Perspect Sex Reprod Health. 2008;40:6-16.
2. Liu S, Joseph KS, Kramer MS, et al. Relationship of prenatal diagnosis and pregnancy termination to overall infant mortality in Canada. JAMA. 2002;287: 1561-1567. (Pubitemid 34270002)
3. Autry AM, Hayes EC, Jacobson GF, et al. A comparison of medical induction and dilation and evacuation for secondtrimester abortion. Am J Obstet Gynecol. 2002;187:393-397.
4. Bartlett LA, Berg CJ, Shulman HB, et al. Risk factors for legal induced abortionrelated mortality in the United States. Obstet Gynecol. 2004;103:729-737. (Pubitemid 40459035)
5. Kapp N, Borgatta L, Stubblefield P, et al. Mifepristone in second-trimester medical abortion: a randomized controlled trial. Obstet Gynecol. 2007;110:1304-1310. (Pubitemid 351326074)
6. Lalitkumar S, Bygdeman M, Gemzell-Danielsson K. Mid-trimester induced abortion: a review. Hum Reprod Update. 2007;13:37-52.
7. Meckstroth KR, Whitaker AK, Bertisch S, et al. Misoprostol administered by epithelial routes: Drug absorption and uterine response. Obstet Gynecol. 2006; 108:582-590. (Pubitemid 44337099)
8. Tang OS, Lau WN, Chan CC, et al. A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy. BJOG. 2004;111:1001-1005. (Pubitemid 39223052)
9. vonHertzenH, Piaggio G, WojdylaD, et al. Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomized controlled equivalence trial. Hum Reprod. 2009;1:106-112.
10. Dickinson JE, Evans SF, The optimization of intravaginal misoprostol dosing schedules in second-trimester pregnancy termination. Am J Obstet Gynecol. 2002; 186:470-474. (Pubitemid 34234159)
11. Wong KS, Ngai CS, Yeo EL, et al. A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: a randomized comparative trial. Hum Reprod. 2000;15:709-712.
12. Wong KS, Ngai CS, Wong AY, et al. Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy. A randomized trial. Contraception. 1998;58:207-210.
13. Jain JK, Mishell DR, Jr. A comparison of misoprostol with and without laminaria tents for induction of second-trimester abortion. Am J Obstet Gynecol. 1996; 175:173-177.
14. Chai J, Tang OS,HongQQ, et al.Arandomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion. Hum Reprod. 2009;1:1-5.
15. Tang OS, Chan CC, Kan AS, et al. A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12-20 weeks gestation. Hum Reprod. 2005;20:3062-3066.
16. Hamoda H, Ashok PW, Flett GM, et al. Arandomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation. BJOG. 2005;112:1102-1108. (Pubitemid 41632666)
17. el-Refaey H, Templeton A. Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens. Hum Reprod. 1995;10:475-478.
18. Fiala C, Swahn ML, Stephansson O, et al. The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13-22 weeks gestation. Hum Reprod. 2005;20: 3072-3077. (Pubitemid 41662658)
19. RCOG, The Care of Women Requesting Induced Abortion. Guidelines No. 7. 2004, London: RCOG.
20. Jackson RA, Teplin VL, Drey EA, et al. Digoxin to facilitate late second-trimester abortion: a randomized, masked, placebo-controlled trial. Obstet Gynecol. 2001;97:471-476.
21. Isada NB, Pryde PG, Johnson MP, et al. Fetal intracardiac potassium chloride injection to avoid the hopeless resuscitation of an abnormal abortus: I. Clinical issues. Obstet Gynecol. 1992;80:296-299.
22. Molaei M, Jones HE, Weiselberg T, et al. Effectiveness and safety of digoxin to induce fetal demise prior to second-trimester abortion. Contraception. 2008;77: 223-235.
23. Pasquini L, Pontello V, Kumar S. Intracardiac injection of potassium chloride as method for feticide: experience from a single UK tertiary centre. BJOG. 2008; 115:528-531. (Pubitemid 351225153)
24. Coke GA, Baschat AA, Mighty HE, et al. Maternal cardiac arrest associated with attempted fetal injection of potassium chloride. Int J Obstet Anesth. 2004;13: 287-290.
25. Gill P, Cyr D, Afrakhtah M, et al. Induction of fetal demise in advanced pregnancy terminations: report on a funic potassium chloride protocol. Fetal Diagn Ther.1994;9:278-282. (Pubitemid 24235129)
26. Daltveit AK, TollanesMC, Pihlstrom H, et al. Cesarean delivery and subsequent pregnancies. Obstet Gynecol. 2008;111: 1327-1334.
27. Steinauer JE, Diedrich JT, Wilson MW, et al. Uterine artery embolization in postabortion hemorrhage. Obstet Gynecol. 2008;111:881-889.